Bitwise Bitcoin Strategy Optimum Roll ETF (BITC)
- Previous Close
44.40 - Open
46.41 - Bid 46.27 x 1300
- Ask 46.65 x 1300
- Day's Range
46.41 - 46.41 - 52 Week Range
22.42 - 57.54 - Volume
449 - Avg. Volume
5,245 - Net Assets 10.87M
- NAV 46.76
- PE Ratio (TTM) --
- Yield 4.33%
- YTD Daily Total Return 40.33%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 0.88%
The fund seeks to achieve its investment objective through managed exposure to bitcoin futures contracts (“bitcoin futures contracts”) and investments in short-term debt securities. The fund does not invest directly in bitcoin. The fund will seek to invest in those bitcoin futures contracts that provide the highest implied roll yield. The fund is non-diversified.
Bitwise Investments
Fund Family
Digital Assets
Fund Category
10.87M
Net Assets
2023-03-20
Inception Date
Performance Overview: BITC
View MoreTrailing returns as of 9/19/2024. Category is Digital Assets.
People Also Watch
Holdings: BITC
View MoreTop 1 Holdings (30.42% of Total Assets)
Recent News: BITC
View More
Research Reports: BITC
View MoreDaily – Vickers Top Buyers & Sellers for 08/23/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 03/20/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Downgrading to HOLD from BUY
Based in Sunnyvale, California, Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR combines the surgical principles of neuroprotection with minimally invasive endovascular techniques to treat carotid artery blockages that may cause strokes. The TCAR procedure involves threading a balloon catheter into the carotid artery from an incision near the groin to expand the narrowed artery. In parallel with the catheter procedure, another device, the ENROUTE Neuroprotection System (NPS), is used to temporarily reverse blood flow to the brain - thus preventing any broken off clots from reaching the brain and potentially causing a stroke.
RatingPrice TargetWhat does Argus have to say about VRE?
VERIS RESIDENTIAL INC has an Investment Rating of HOLD; a target price of $18.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target